Today, the Executive VP, COO & CFO of Cryolife (NYSE: CRY), David Ashley Lee, sold shares of CRY for $256.9K.
Following David Ashley Lee’s last CRY Sell transaction on November 13, 2017, the stock climbed by 6.4%. In addition to David Ashley Lee, 4 other CRY executives reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on Cryolife’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $61.95 million and GAAP net loss of $3.82 million. In comparison, last year the company earned revenue of $45.06 million and had a net profit of $2.18 million. Currently, Cryolife has an average volume of 74.64K.
The insider sentiment on Cryolife has been negative according to 65 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
CryoLife, Inc. is a medical devices company, which engages in the processing and distribution of implantable human tissues for use in cardiac and vascular surgeries. It operates through the Medical Devices and Preservation Services segments.
